United States Department of Defense

11 articles with United States Department of Defense

• Hemopure® to be evaluated in groundbreaking clinical study of trauma patients in the prehospital setting, sponsored by the United States Department of Defense, and coordinated by Stellenbosch University

  11/8/2018

  Patient enrollment expected to commence in mid 2019

• 

  FDA Action Alert: Merck’s Keytruda in Lung Cancer, Trevena and AcelRx Drugs for Pain

  10/29/2018

  As we end October and head into November, the Food and Drug Administration (FDA) continues its work. This upcoming week has several PDUFA action dates for drug applications. Here’s a look.

• U.S. Department of Defense Awards $3.3 Million Grant to Alivio Therapeutics

  9/12/2018

  Research award will support preclinical activities to advance product candidate for the treatment of interstitial cystitis/bladder pain syndrome into the clinic

• BrainScope Receives $4.5 Million Department of Defense Contract to Add Ocular Assessment to Future Concussion Products

  9/4/2018

  BrainScope today announced that it has been awarded a research contract by the United States Department of Defense (DOD) valued at $4.5 million to create and integrate ocular capabilities into its handheld, multi-parameter mild Traumatic Brain Injury (mTBI) and concussion products.

• 

  FDA Clears SPR Therapeutics’ Non-Opioid Neurostimulation Pain Therapies

  8/21/2018

  The U.S. Food and Drug Administration (FDA) cleared Cleveland-based SPR Therapeutics’ SPRINT endura (single lead) and extensa (dual lead) Peripheral Nerve Stimulation (PNS) Systems for controlling pain.

• The United States Department of Defense Awards $2.3 Million in Funding for Lupus Research

  8/24/2011

• Revolutions Medical Corporation's RevVac Safety Syringe is Cleared by United States Department of Defense Logistics Agency for Inclusion in Medical Supply Catalog

  7/8/2011

• Morphotek Inc. Receives Additional $1.6M in Funding from The United States Department of Defense to Develop Therapeutic Antibodies Against Microbial Bioweapons

  11/20/2008

• Morphotek Inc. Receives $1.7M in Funding from the Morphotek Inc. to Develop Therapeutic Antibodies Against Microbial Bioweapons

  6/23/2008

• U.S.-Funded Stem Cell Research In Sweden Open To Misinterpretation

  3/25/2004

• Ultra-Scan Corporation Release: Ultra-Scan(TM) Ultrasonic Biometric Readers Pass Military, UL, FCC And European Testing Standards

  12/15/2003